Effect of Kun'an Granule on Serum Hormone Level in Rats with Hyperprolactinemia
Hengxia Zhao
Abstract
Hengxia Zhao
Abstract
[Objective] To investigate the effect of Kun'an Granule (KG) on serum hormone level in rats with hyperprolactinemia [ Methods ] Rats were randomized to five groups: group A ( mimic operation) , group B (model control), group C (bromocriptine), group D (low-dose KG) and group E (high-dose KG). Except group A, the other four groups were implanted with pituitary for modeling. Group C was treated with bromocriptine 1 mg/kg, group D with gastric infusion of KG 4 g/kg and group E with KG 12 g/kg. The treatment lasted 34 days. Serum levels of prolactin (PRL), testosterone (T), follicle-stimulating hormone (FSH), luteinizing hormone (LH) and estrogen (E2) were detected before and after treatment and the differences between groups were compared. [ Results ] Serum PRL and T levels were increased and LH, FSH and E2 levels decreased in group B (P 0.05 or P 0.01 compared with group A). Serum PRL and T levels were decreased and LH, FSH and E2 levels increased in groups C, D and E to some extent (P 0.05 or P 0.01 compared with group B). [Conclusion] KG can regulate the serum hormone levels in rats with hyperprolactinemia by decreasing PRL and T levels and by increasing LH, FSH and E2 levels.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
[Objective] To investigate the effect of Kun'an Granule (KG) on serum hormone level in rats with hyperprolactinemia [ Methods ] Rats were randomized to five groups: group A ( mimic operation) , group B (model control), group C (bromocriptine), group D (low-dose KG) and group E (high-dose KG). Except group A, the other four groups were implanted with pituitary for modeling. Group C was treated with bromocriptine 1 mg/kg, group D with gastric infusion of KG 4 g/kg and group E with KG 12 g/kg. The treatment lasted 34 days. Serum levels of prolactin (PRL), testosterone (T), follicle-stimulating hormone (FSH), luteinizing hormone (LH) and estrogen (E2) were detected before and after treatment and the differences between groups were compared. [ Results ] Serum PRL and T levels were increased and LH, FSH and E2 levels decreased in group B (P 0.05 or P 0.01 compared with group A). Serum PRL and T levels were decreased and LH, FSH and E2 levels increased in groups C, D and E to some extent (P 0.05 or P 0.01 compared with group B). [Conclusion] KG can regulate the serum hormone levels in rats with hyperprolactinemia by decreasing PRL and T levels and by increasing LH, FSH and E2 levels.
Key concepts: Bromocriptine, Prolactin, Internal medicine, Endocrinology, Luteinizing hormone, Follicle-stimulating hormone, Hormone, Testosterone (patch)